The next big hurdle in the Johnson & Johnson talcum powder lawsuits is approaching quickly according to an article by Fierce Pharma. The company is set to try and challenge evidence that will be submitted for trial by the plaintiff’s attorneys.
New Jersey Hearing
At a hearing set for next Monday July 29, 2019 the company will challenge the truthfulness of the evidence being submitted for the trial. This trial involves about 14,200 lawsuits combined together. The plaintiff’s claim that Johnson & Johnson’s talcum powder products caused their diagnosis of ovarian cancer & mesothelioma due to the presence of asbestos in their talc. They also claim that Johnson & Johnson was aware that their talc was not safe, but purposely hid that knowledge from the public.
Loss In Delaware
Johnson & Jonson have been hit with some pretty big verdicts against them in the courtroom. On top of that, the company was recently denied a motion to move all cases to federal court in Delaware, where their talc supplier Imerys Talc America is currently undergoing bankruptcy proceedings. The company is now subject to a criminal investigation by the Department of Justice.
Pivotal Decision for Talc Cases
Monday’s decision can greatly impact the shape of future talc cases moving forward. For now it remains to be seen whether the momentum will continue in favor of the plaintiffs or if there will be a definite shift.
Diagnosed With Ovarian Cancer and/or Mesothelioma?
If you or a loved one has been diagnosed with ovarian cancer and/or mesothelioma and have regularly used Johnson & Johnson baby powder or their other talcum based products, contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on ovarian cancer and talcum powder for more information.